tradingkey.logo
tradingkey.logo
Search

C4 Therapeutics Inc

CCCC
Add to Watchlist
3.480USD
-0.180-4.92%
Close 07-31 16:00ETQuotes delayed by 15 min
384.77MMarket Cap
LossP/E TTM

CCCC Financials

See C4 Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

C4 Therapeutics Inc Earnings Date

Latest Release
May 12, 2026
EPS / Forecast
-0.20/-0.37
Revenue / Forecast
6.15M/3.33M
Period
FY2025 Earnings
Revenue(YoY)
35.95M
1.02%
EPS(YoY)
-1.27
16.57%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
46.36%-0.20
-158.70%-1.27
-25.13%-0.44
-42.33%-0.37
10.33%-0.37
27.80%-0.49
35.52%-0.35
64.84%-0.26
41.57%-0.41
10.71%-0.68
---0.55
---0.73
---0.71
---0.76
----
----
----
----
----
----
Revenue
-15.00%6.15M
112.79%11.02M
-26.90%11.23M
-46.17%6.46M
138.17%7.24M
58.75%5.18M
38.75%15.36M
350.68%12.01M
-19.15%3.04M
14.26%3.26M
63.93%11.07M
-80.74%2.66M
-50.89%3.76M
-85.79%2.85M
-20.54%6.75M
41.44%13.83M
3.07%7.65M
143.02%20.08M
0.63%8.50M
--9.78M
Net Profit
4.53%-25.13M
40.75%-20.49M
-30.41%-32.17M
-46.87%-26.02M
7.19%-26.32M
0.52%-34.57M
8.77%-24.67M
50.68%-17.72M
18.46%-28.36M
6.54%-34.75M
15.40%-27.04M
-31.04%-35.92M
-9.99%-34.78M
-137.48%-37.19M
-29.47%-31.96M
-21.40%-27.41M
-50.78%-31.62M
-36.97%-15.66M
8.74%-24.68M
---22.58M
Net Margin
-12.32%-408.47%
56.26%-292.08%
-78.39%-286.43%
-172.84%-402.60%
61.03%-363.66%
37.34%-667.82%
34.25%-160.57%
89.06%-147.56%
-0.86%-933.23%
18.20%-1065.75%
---244.19%
---1348.42%
---925.25%
---1302.91%
----
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
----
-100.00%0.00%
-100.00%0.00%
--0.00%
--2.76%
--2.75%
--2.67%
----
----
----
----
----
----
Revenue
-15.00%6.15M
112.79%11.02M
-26.90%11.23M
-46.17%6.46M
138.17%7.24M
58.75%5.18M
38.75%15.36M
350.68%12.01M
-19.15%3.04M
14.26%3.26M
63.93%11.07M
-80.74%2.66M
-50.89%3.76M
-85.79%2.85M
-20.54%6.75M
41.44%13.83M
3.07%7.65M
143.02%20.08M
0.63%8.50M
--9.78M
Operating profit
4.73%-27.79M
38.62%-23.14M
16.16%-23.68M
-32.92%-28.50M
2.08%-29.16M
-0.75%-37.71M
-1.57%-28.24M
42.92%-21.44M
17.79%-29.78M
2.26%-37.43M
14.41%-27.81M
-37.19%-37.57M
-15.49%-36.23M
-151.02%-38.29M
-33.95%-32.49M
-23.82%-27.38M
-52.95%-31.37M
19.30%-15.26M
-32.18%-24.25M
---22.12M
Net Profit
4.53%-25.13M
40.75%-20.49M
-30.41%-32.17M
-46.87%-26.02M
7.19%-26.32M
0.52%-34.57M
8.77%-24.67M
50.68%-17.72M
18.46%-28.36M
6.54%-34.75M
15.40%-27.04M
-31.04%-35.92M
-9.99%-34.78M
-137.48%-37.19M
-29.47%-31.96M
-21.40%-27.41M
-50.78%-31.62M
-36.97%-15.66M
8.74%-24.68M
---22.58M
Current assets
5.52%245.37M
0.13%258.11M
-24.29%206.86M
-18.59%224.73M
-16.83%232.53M
-4.95%257.77M
22.15%273.23M
0.60%276.04M
0.41%279.59M
-5.69%271.19M
-31.27%223.69M
-13.81%274.39M
-8.09%278.45M
-11.71%287.56M
-21.06%325.46M
-33.34%318.37M
-5.92%302.95M
-14.52%325.69M
97.34%412.29M
113.75%477.56M
Total current liabilities
-33.25%27.25M
-26.88%33.03M
-16.97%35.95M
-17.98%44.46M
-25.81%40.82M
5.64%45.18M
43.02%43.29M
12.36%54.20M
39.71%55.02M
-4.00%42.77M
-33.13%30.27M
4.53%48.24M
-16.19%39.38M
-13.07%44.55M
-7.02%45.27M
4.49%46.15M
24.79%46.99M
16.86%51.25M
21.69%48.69M
25.78%44.17M
Total assets
2.92%328.86M
2.71%359.07M
-29.40%265.49M
-22.19%296.53M
-19.79%319.52M
-7.13%349.60M
12.93%376.06M
1.62%381.09M
0.59%398.37M
-12.62%376.45M
-27.83%333.01M
-23.85%375.01M
-23.17%396.04M
-14.98%430.84M
-9.15%461.44M
-6.80%492.48M
37.83%515.49M
26.65%506.76M
121.67%507.91M
116.95%528.42M
Total liabilities
-23.93%94.61M
-23.30%102.49M
-16.73%111.08M
-8.63%122.46M
-11.21%124.38M
2.52%133.62M
14.03%133.40M
-5.14%134.03M
4.88%140.09M
-7.96%130.34M
-18.34%116.99M
-4.45%141.30M
-11.52%133.57M
20.87%141.61M
31.27%143.26M
32.04%147.88M
36.86%150.96M
-1.83%117.16M
-15.09%109.13M
-11.54%111.99M
Total equity
20.04%234.25M
18.80%256.59M
-36.37%154.41M
-29.55%174.06M
-24.45%195.14M
-12.24%215.99M
12.33%242.66M
5.71%247.06M
-1.60%258.28M
-14.91%246.11M
-32.11%216.02M
-32.18%233.71M
-28.00%262.47M
-25.76%289.23M
-20.21%318.18M
-17.25%344.59M
38.23%364.53M
38.75%389.61M
296.42%398.78M
256.05%416.43M
Net operating income
10.04%-29.94M
-23.49%-22.14M
-29.31%-31.21M
-142.40%-12.06M
-83.71%-33.28M
25.31%-17.93M
21.41%-24.13M
73.82%-4.97M
45.30%-18.12M
17.57%-24.01M
-9.59%-30.71M
14.41%-19.00M
-24.55%-33.13M
-13.47%-29.13M
-52.63%-28.02M
-23.29%-22.20M
-6.67%-26.60M
-19.18%-25.67M
-27.52%-18.36M
---18.00M
Net investment
-44.54%16.15M
-690.59%-80.73M
2422.22%4.09M
432.49%38.92M
154.55%29.13M
-57.21%13.67M
-99.72%162.00K
-177.28%-11.71M
-199.75%-53.40M
244.09%31.95M
189.87%57.73M
-54.41%15.15M
1436.94%53.53M
115.63%9.28M
119.79%19.91M
2.45%33.23M
93.51%-4.00M
-9.58%-59.41M
-211.34%-100.63M
--32.43M
Net financing
1104.35%462.00K
105857.14%118.67M
-26.01%7.77M
-100.00%0.00
-100.13%-46.00K
-99.81%112.00K
197.70%10.51M
118.10%135.00K
5155.99%34.58M
122606.38%57.67M
-3078.67%-10.75M
-388.03%-746.00K
-242.50%-684.00K
-89.91%47.00K
-38.18%361.00K
-99.85%259.00K
417.88%480.00K
-99.76%466.00K
-76.63%584.00K
--170.50M

FAQs

What is the total revenue of C4 Therapeutics Inc?

According to C4 Therapeutics Inc's FY2025 earnings report, its total revenue reached 35.95M, with a year-on-year change of 35.58M.

What are the current assets of C4 Therapeutics Inc?

According to C4 Therapeutics Inc's FY2025 earnings report, its current assets were 258.11M, with a year-on-year change of 0.13.

What are the total assets of C4 Therapeutics Inc?

According to C4 Therapeutics Inc's FY2025 earnings report, its total assets of C4 Therapeutics Inc were 359.07M, with a year-on-year change of 2.71.

What are the total liabilities of C4 Therapeutics Inc?

According to C4 Therapeutics Inc's FY2025 earnings report, its total liabilities of C4 Therapeutics Inc were 102.49M, with a year-on-year change of -23.30.

What is the total equity of C4 Therapeutics Inc?

According to C4 Therapeutics Inc's FY2025 earnings report, its total equity of C4 Therapeutics Inc was 256.59M, with a year-on-year change of 18.80.

What is the net operating income of C4 Therapeutics Inc?

According to C4 Therapeutics Inc's FY2025 earnings report, its net operating income of C4 Therapeutics Inc was -104.49M, with a year-on-year change of 10.83.

What is the net investment of C4 Therapeutics Inc?

According to C4 Therapeutics Inc's FY2025 earnings report, its net investment of C4 Therapeutics Inc was -8.60M, with a year-on-year change of 83.22.

What is the net financing of C4 Therapeutics Inc?

According to C4 Therapeutics Inc's FY2025 earnings report, its net financing of C4 Therapeutics Inc was 126.40M, with a year-on-year change of 178.80.

What is the Earnings Per Share (EPS) of C4 Therapeutics Inc?

According to C4 Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.27, with a year-on-year change of 16.57.

What is the net income of C4 Therapeutics Inc?

According to C4 Therapeutics Inc's FY2025 earnings report, its net income was -104.99M, with a year-on-year change of 0.31.

What is the net margin of C4 Therapeutics Inc?

According to C4 Therapeutics Inc's FY2025 earnings report, its net profit margin was -292.08, with a year-on-year change of 1.31.

What is the Return on Equity (ROE) of C4 Therapeutics Inc?

According to C4 Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -44.44, with a year-on-year change of 2.52.

What is the Return on Assets (ROA) of C4 Therapeutics Inc?

According to C4 Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -29.63, with a year-on-year change of -2.14.

What is the operating profit of C4 Therapeutics Inc?

According to C4 Therapeutics Inc's FY2025 earnings report, its operating profit was -104.49M, with a year-on-year change of 10.83.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.